Tamoxifen can increase 10-year survival rates for women with ER-positive breast cancers

This review has been withdrawn.

The reason for withdrawal and previous versions are archived and accessible within the withdrawn record in the Cochrane Library.

Published:

8 October 2008

Authors:

Clarke MJ

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Clarke MJ. Tamoxifen for early breast cancer. Cochrane Database of Systematic Reviews 2008, Issue 4. Art. No.: CD000486. DOI: 10.1002/14651858.CD000486.pub2